Senseonics HoldingsSENS -0.38%60 Buyback Yield % is -27.90 as of Jul. 08, 2026. GuruFocus rates SENS with a GF Score™ of 60/100 and a GF Value™ of $14.22 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 345 Medical Devices & Instruments companies, Senseonics Holdings ranks worse than 82.9% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Senseonics Holdings Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Senseonics Holdings's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SENS vs LAB, TMCI, SGHT: Buyback Yield % Comparison
For the Medical Devices subindustry, Senseonics Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senseonics Holdings Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Senseonics Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Senseonics Holdings (SENS) has a Buyback Yield % of -27.90 as of Jul. 08, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Senseonics Holdings and its competitors. According to the industry distribution chart, Senseonics Holdings ranks #286 out of 345 companies in the Medical Devices & Instruments industry, placing it in the top 82.9%.
Is Senseonics Holdings' Buyback Yield % too high?
Senseonics Holdings' current Buyback Yield % is -27.90. Based on the distribution chart, Senseonics Holdings ranks #286 out of 345 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Senseonics Holdings has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senseonics Holdings' Buyback Yield % compare to LAB and TMCI?
According to the Medical Devices & Instruments industry distribution chart, Senseonics Holdings ranks #286 out of 345 companies for Buyback Yield %. This places Senseonics Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Senseonics Holdings and its competitors. Senseonics Holdings's current Buyback Yield % is -27.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senseonics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Senseonics Holdings (SENS) is currently considered Possible Value Trap. The stock's GF Value™ is $14.22, compared to a current price of $5.31 — trading 62.7% below its estimated fair value. The current Buyback Yield % is -27.90. Senseonics Holdings' overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Senseonics Holdings (SENS), the current Buyback Yield % is -27.90 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Senseonics Holdings (SENS) Overvalued in 2026?
Based on GuruFocus' analysis, Senseonics Holdings stock appears to be undervalued.
The current stock price of $5.31 is trading 62.7% below its estimated GF Value™ of $14.22.
GuruFocus considers Senseonics Holdings to be Possible Value Trap.
Key valuation signals for SENS:
Buyback Yield %: -27.90
GF Value™: $14.22 vs. price of $5.31 (62.7% below fair value)
No single metric tells the full story. See the SENS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
60GF Score
Get the complete analysis for SENS
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SENS has been successfully added to your 
